Celecoxib and sulindac sulfide elicit anticancer effects on PIK3CA-mutated head and neck cancer cells through endoplasmic reticulum stress, reactive oxygen species, and mitochondrial dysfunction.

MLA

Thi Thanh Nguyen, Nga, and Sang Yoon Lee. “Celecoxib and Sulindac Sulfide Elicit Anticancer Effects on PIK3CA-Mutated Head and Neck Cancer Cells through Endoplasmic Reticulum Stress, Reactive Oxygen Species, and Mitochondrial Dysfunction.” Biochemical Pharmacology, vol. 224, June 2024, p. 116221. EBSCOhost, https://doi.org/10.1016/j.bcp.2024.116221.

APA

Thi Thanh Nguyen, N., & Yoon Lee, S. (2024). Celecoxib and sulindac sulfide elicit anticancer effects on PIK3CA-mutated head and neck cancer cells through endoplasmic reticulum stress, reactive oxygen species, and mitochondrial dysfunction. Biochemical Pharmacology, 224, 116221. https://doi.org/10.1016/j.bcp.2024.116221

Chicago

Thi Thanh Nguyen, Nga, and Sang Yoon Lee. 2024. “Celecoxib and Sulindac Sulfide Elicit Anticancer Effects on PIK3CA-Mutated Head and Neck Cancer Cells through Endoplasmic Reticulum Stress, Reactive Oxygen Species, and Mitochondrial Dysfunction.” Biochemical Pharmacology 224 (June): 116221. doi:10.1016/j.bcp.2024.116221.